ey0020.8-2 | Clinical Trials – New Treatments | ESPEYB20
CK Boughton
, JM Allen
, J Ware
, ME Wilinska
, S Hartnell
, A Thankamony
, T Randell
, A Ghatak
, REJ Besser
, D Elleri
, N Trevelyan
, FM Campbell
, J Sibayan
, P Calhoun
, R Bailey
, G Dunseath
, R Hovorka
, CLOuD Consortium
Brief summary: In this multicenter, open-label, parallel-group, randomized trial, 97 adolescents (aged 1016.9 years) were randomized within 21 days after the diagnosis of type 1 diabetes (T1D) to receive either hybrid closed-loop therapy or standard insulin therapy (control) for 24 months. Although closed-loop therapy was associated with better glycemic outcomes, there were no differences in C-peptide between the two groups.The Closed Loop from Ons...